Terms: = Uterine cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Prognosis
28 results:
1. Prognostic and therapeutic potential of stat3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis.
Janjua D; Thakur K; Aggarwal N; Chaudhary A; Yadav J; Chhokar A; Tripathi T; Joshi U; Senrung A; Bharti AC
Crit Rev Oncol Hematol; 2024 May; 197():104346. PubMed ID: 38608913
[TBL] [Abstract] [Full Text] [Related]
2. CD146
Yu Z; Zhang Q; Wei S; Zhang Y; Zhou T; Zhang Q; Shi R; Zinovkin D; Pranjol ZI; Zhang J; Wang H
Cell Commun Signal; 2024 Mar; 22(1):170. PubMed ID: 38459564
[TBL] [Abstract] [Full Text] [Related]
3. The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial cancer by Blocking LIF/LIFR Oncogenic Signaling.
Spencer N; Rodriguez Sanchez AL; Gopalam R; Subbarayalu P; Medina DM; Yang X; Ramirez P; Randolph L; Aller EJ; Santhamma B; Rao MK; Tekmal RR; Nair HB; Kost ER; Vadlamudi RK; Viswanadhapalli S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139260
[TBL] [Abstract] [Full Text] [Related]
4. Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of stat3/CCL2 signaling pathway in uterine sarcoma.
Hwang JR; Cho YJ; Ryu JY; Choi JY; Choi JJ; Sa JK; Kim HS; Lee JW
Biomed Pharmacother; 2023 Dec; 168():115792. PubMed ID: 37924789
[TBL] [Abstract] [Full Text] [Related]
5. Physical interaction between stat3 and AP1 in cervical carcinogenesis: Implications in HPV transcription control.
Thakur K; Janjua D; Aggarwal N; Chhokar A; Yadav J; Tripathi T; Chaudhary A; Senrung A; Shrivastav A; Bharti AC
Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166817. PubMed ID: 37532113
[TBL] [Abstract] [Full Text] [Related]
6. Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma.
Deng Y; Tan Y; Zhou D; Bai Y; Cao T; Zhong C; Huang W; Ou Y; Guo L; Liu Q; Yin D; Chen L; Luo X; Sun D; Sheng X
Front Immunol; 2022; 13():923194. PubMed ID: 35935940
[TBL] [Abstract] [Full Text] [Related]
7. Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer.
Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
J Clin Lab Anal; 2022 Apr; 36(4):e24315. PubMed ID: 35244291
[TBL] [Abstract] [Full Text] [Related]
8. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract] [Full Text] [Related]
9. The anti-neoplastic activities of aloperine in HeLa cervical cancer cells are associated with inhibition of the IL-6-JAK1-stat3 feedback loop.
Chen YD; Cai FY; Mao YZ; Yang YS; Xu K; Liu XF; Fan WW; Chen W; Jiang FQ; Zhang H
Chin J Nat Med; 2021 Nov; 19(11):815-824. PubMed ID: 34844720
[TBL] [Abstract] [Full Text] [Related]
10.
Han GH; Kim J; Yun H; Cho H; Chung JY; Kim JH; Hewitt SM
Cancer Genomics Proteomics; 2021; 18(6):699-713. PubMed ID: 34697063
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathological and prognostic value of stat3/p-stat3 in cervical cancer: A meta and bioinformatics analysis.
Shi S; Ma HY; Zhang ZG
Pathol Res Pract; 2021 Nov; 227():153624. PubMed ID: 34571355
[TBL] [Abstract] [Full Text] [Related]
12. Circ-E2F3 promotes cervical cancer progression by inhibiting microRNA-296-5p and increasing stat3 nuclear translocation.
Cao X; Ma Q; Wang B; Qian Q; Xi Y
Ann N Y Acad Sci; 2022 Jan; 1507(1):84-98. PubMed ID: 34468993
[TBL] [Abstract] [Full Text] [Related]
13. Alantolactone inhibits cervical cancer progression by downregulating BMI1.
Sun X; Xu H; Dai T; Xie L; Zhao Q; Hao X; Sun Y; Wang X; Jiang N; Sang M
Sci Rep; 2021 Apr; 11(1):9251. PubMed ID: 33927214
[TBL] [Abstract] [Full Text] [Related]
14. Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the stat3/P53 pathway.
Wang J; Wu Y; Li Y; Wang Y; Shen F; Zhou J; Chen Y
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649833
[TBL] [Abstract] [Full Text] [Related]
15. cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels.
Zhou C; Wei W; Ma J; Yang Y; Liang L; Zhang Y; Wang Z; Chen X; Huang L; Wang W; Wu S
Mol Ther; 2021 Apr; 29(4):1512-1528. PubMed ID: 33388421
[TBL] [Abstract] [Full Text] [Related]
16. Pan-cancer analysis of alternative splicing regulator heterogeneous nuclear ribonucleoproteins (hnRNPs) family and their prognostic potential.
Li H; Liu J; Shen S; Dai D; Cheng S; Dong X; Sun L; Guo X
J Cell Mol Med; 2020 Oct; 24(19):11111-11119. PubMed ID: 32915499
[TBL] [Abstract] [Full Text] [Related]
17. Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving stat3 and tumor microenvironment-related genes.
Dong P; Xiong Y; Yue J; Xu D; Ihira K; Konno Y; Kobayashi N; Todo Y; Watari H
J Exp Clin Cancer Res; 2019 Jul; 38(1):295. PubMed ID: 31287002
[TBL] [Abstract] [Full Text] [Related]
18. LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis.
Zhang YY; Li M; Xu YD; Shang J
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3664-3671. PubMed ID: 31114991
[TBL] [Abstract] [Full Text] [Related]
19. Growth arrest-specific 5 attenuates cisplatin-induced apoptosis in cervical cancer by regulating stat3 signaling via miR-21.
Yao T; Lu R; Zhang J; Fang X; Fan L; Huang C; Lin R; Lin Z
J Cell Physiol; 2019 Jun; 234(6):9605-9615. PubMed ID: 30352127
[TBL] [Abstract] [Full Text] [Related]
20. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
[TBL] [Abstract] [Full Text] [Related]
[Next]
